Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Adverum Biotechnologies, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ADVM is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 50
- −9 vs. Q2 2025
- Shares held
- 14.1M
- +63.5K (+0.5%) vs. Q2 2025
- Total value
- $63.8M
- +$33.6M (+111.6%) vs. Q2 2025
- New holders
- 6
- 7 more added
- Sold out
- 15
- 23 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 3,057,526 | $13.9M | 12.74% | 00.0% | Unchanged |
| Principia Wealth Advisory, LLC | 2,077,946 | $9.41M | 6.72% | +48,830+2.4% | Added |
| Frazier Life Sciences Management, L.P. | 2,077,431 | $9.41M | 0.28% | +1,008,187+94.3% | Added |
| TCG Crossover Management, LLC | 1,668,174 | $7.56M | 0.37% | −128,308−7.1% | Reduced |
| Vanguard Group Inc | 872,041 | $3.95M | 0.00% | −11,896−1.3% | Reduced |
| 5AM Venture Management, LLC | 541,666 | $2.45M | 0.90% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 506,821 | $2.30M | 1.08% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 402,581 | $1.82M | 0.00% | −94,706−19.0% | Reduced |
| Renaissance Technologies LLC | 363,496 | $1.65M | 0.00% | −207,173−36.3% | Reduced |
| Pale Fire Capital SE | 363,282 | $1.65M | 0.18% | +4,558+1.3% | Added |
| Millennium Management LLC | 324,422 | $1.47M | 0.00% | −17,918−5.2% | Reduced |
| BlackRock, Inc. | 311,394 | $1.41M | 0.00% | −103,091−24.9% | Reduced |
| Soleus Capital Management, L.P. | 287,246 | $1.30M | 0.07% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 234,541 | $1.06M | 0.00% | −51,509−18.0% | Reduced |
| Geode Capital Management, LLC | 184,762 | $837.3K | 0.00% | 00.0% | Unchanged |
| Regeneron Pharmaceuticals, Inc. | 180,909 | $819.5K | 0.12% | 00.0% | Unchanged |
| Warren Averett Asset Management, LLC | 160,991 | $729.3K | 0.01% | +413+0.3% | Added |
| Two Sigma Investments, LP | 88,670 | $401.7K | 0.00% | +69,913+372.7% | Added |
| State Street Corp | 68,734 | $311.4K | 0.00% | −90−0.1% | Reduced |
| Quinn Opportunity Partners LLC | 41,418 | $187.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 38,071 | $172.5K | 0.00% | +27,390+256.4% | Added |
| Marshall Wace, LLP | 28,367 | $128.5K | 0.00% | −21,261−42.8% | Reduced |
| Northern Trust Corp | 28,058 | $127.1K | 0.00% | −6,333−18.4% | Reduced |
| Susquehanna International Group, LLP | 26,255 | $118.9K | 0.00% | −32,956−55.7% | Reduced |
| Qube Research & Technologies Ltd | 21,730 | $98.4K | 0.00% | −8,949−29.2% | Reduced |
| Morgan Stanley | 17,555 | $79.5K | 0.00% | −35,382−66.8% | Reduced |
| Citadel Advisors LLC | 17,267 | $78.2K | 0.00% | −61,004−77.9% | Reduced |
| D. E. Shaw & Co., Inc. | 17,153 | $77.7K | 0.00% | −9,599−35.9% | Reduced |
| Royal Bank of Canada | 13,465 | $61.0K | 0.00% | +10,696+386.3% | Added |
| JustInvest LLC | 12,805 | $58.0K | 0.00% | +12,805 | New |
| XTX Topco Ltd | 12,655 | $57.3K | 0.00% | −17,100−57.5% | Reduced |
| Squarepoint Ops LLC | 11,271 | $51.1K | 0.00% | −10,381−47.9% | Reduced |
| UBS Group AG | 5,585 | $25.3K | 0.00% | −8,585−60.6% | Reduced |
| Bank of America Corp | 3,614 | $16.4K | 0.00% | −37,652−91.2% | Reduced |
| FMR LLC | 1,933 | $8.76K | 0.00% | −391−16.8% | Reduced |
| Advisor Group Holdings, Inc. | 1,689 | $7.69K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1,000 | $4.51K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 540 | $2.45K | 0.00% | −246−31.3% | Reduced |
| UMA Financial Services, Inc. | 217 | $984 | 0.00% | +217 | New |
| JPMorgan Chase & Co | 182 | $824 | 0.00% | +182 | New |
| Allworth Financial LP | 102 | $463 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 84 | $381 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 50 | $227 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 30 | $136 | 0.00% | −184−86.0% | Reduced |
| Barclays PLC | 21 | $96 | 0.00% | +21 | New |
| GHP Investment Advisors, Inc. | 20 | $91 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 19 | $86 | 0.00% | +19 | New |
| Deutsche Bank AG | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 1 | $5 | 0.00% | +1 | New |
| CWM, LLC | 33 | $0 | 0.00% | −2,120−98.5% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −70,931−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −67,602−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −30,627−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −21,819−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −21,122−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −14,582−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −10,670−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,137−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,916−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Eq Wealth Advisors, LLC | 0 | $0 | 0.00% | −162−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |